Abstract
Cells from patients with Fanconi anemia (FA) show decreased viability and decreased chromosome stability after treatment with DNA cross-linking agents, compared to normal cells. FA cells also show a relative accumulation at the G2/M transition after such treatment. This has suggested a possible checkpoint abnormality. In the studies presented here, treatment with hydroxyurea, caffeine or inhibitors of cell cycle kinases did not reveal abnormalities in survival or chromosome stability in FA-A or FA-D cells. Chromosomal breaks introduced by hydrogen peroxide or methyl methanesulfonate accumulated to the same extent in FA-A or FA-D cells as in normal cells. We conclude that FA-A and FA-D cells respond normally to agents known to alter the cell cycle or introduce DNA strand breaks. FA cells process strand breaks and a variety of DNA monoadducts normally. Our results are compatible with repair of DNA crosslinks being slower in FA than in normal cells and FA cells having normal cell cycle checkpoints.
Similar content being viewed by others
Literature Cited
Fanconi, G. (1967).Semin. Hematol. 4:233–240.
Strathdee, C.A., and Buchwald, M. (1992).Am. J. Pedi. Hemat./Oncol. 14:177–185.
Liu, J., Buchwald, M., Walsh, C., and Young, N. (1994).Blood 84:3995–4007.
Joenje, H., Lo Ten Foe, J.R., Oostra, A.B., van Berkel, C.G.M., Rooimans, M.A., Schroeder-Kurth, T., Wagner, R.D., Gille, J.J.P., Buchwald, M., and Arwert, F. (1995).Blood 86:2156–2160.
Strathdee, C.A., Duncan, A.M.V., and Buchwald, M. (1992).Nature Genet. 1:196–198.
Joenje, H., Oostra, A.B., Wijker, M., di Summa, F.M., van Berkel, C.G.M., Rooimans, M.A., Ebell, W., van Weel, M., Pronk, J.C., Buchwald, M., and Arwert, F. (1997).Am. J. Hum. Genet. 61:940–944.
Strathdee, C.A., Gavish, H., Shannon, W., and Buchwald, M. (1992).Nature 356:763–767.
Youssoufian, H. (1996).J. Clin. Invest. 97:2003–2010.
Yamashita, T., Barber, D.L., Zhu, Y., and D'Andrea, A.D. (1994).Proc. Natl. Acad. Sci. 91:6712–6716.
Youssoufian, H. (1994).Proc. Natl. Acad. Sci. U.S.A. 91:7975–7979.
Grossmann, K.A., Hejna, J.A., and Moses, R.E. (1996).Am. J. Human Genet. (Suppl.)59(4):2138.
Lo Ten Foe, J.R., Rooimans, M.A., Bosnoyan-Collins, L., Alon, N., Wijker, M., Parker, L., Lightfoot, J., Carreau, M., Callen, D.F., Savoia, A., Cheng, N.C., van Berkel, C.G.M., Strunk, M.H.P., Gille, J.J.P., Pals, G., Kruyt, F.A.E., Pronk, J.D., Arwert, F., Buchwald, M., and Joenje, H. (1996).Nature Genet. 14:320–232.
The Fanconi anaemia/Breast cancer consortium. (1996).Nature Genet. 14:324–328.
Saito, H., Hammond, A.T., and Moses, R.E. (1993).Mutat. Res.,294:255–262.
Poot, M., Grob, O., Epe, B., Pflaum, M., and Hoehn, H. (1996)Exp. Cell Res. 222:262–268.
Schindler, D., and Hoehn, H. (1988).Am. J. Med. Genet. 43:429–435.
Ruppitsch, W., Meisslitzer, C., Weirich-Schweiger, H., Klocker, H., Scheidereit, C., Schweiger, M., and Hirsch-Kaufman, M. (1997).Hum. Genet.,99:710–719.
Li, Y., and Youssoufian, H. (1997)J. Clin. Invest. 100:2873–2880.
Kupfer, G.M., and D'Andrea, A.D. (1996).Blood 88:1019–1025.
Dutrillaux, B., Aurias, A., Dutrillaux, A.M., Buriot, D., and Prieur, M. (1982).Hum. Genet.,62:327–332.
Kaiser, T.N., Lojewski, A., Dougherty, C., Juergens, L., Sahar, E., and Latt, S.A. (1982).Cytometry 2:291–297.
Sabatier, L., and Dutrillaux, B. (1988).Hum. Genet. 79:242–244.
Seyschab, H., Bretzel, G., Friedl, R., Schindler, D., Sun, Y., and Hoehn, H. (1994)Mutat. Res.,308:149–157.
Shinomiya, N., Shinomiya, M., Wakiyama, H., Katsura, Y., and Rokutanda, M. (1994).Exp. Cell Res. 210:236–242.
Dutrillaux, B., Aurias, A., Dutrillaux, A.M., Buriot, D., and Prieur, M. (1982).Hum. Genet.,62:327–332.
Crompton, N.E., Hain, J., Jaussi, R., Burkart, W. (1993).Radiation Res. 135:372–379.
Bernhard, E.J., Maity, A., Muschel, R.J., and Gillies McKenna, W. (1994).Radiation Res. 140:393–400.
Mueller, P.R., Coleman, T.R., Kumagai, A., and Dunphy, W.G. (1995).Science 270:86–89.
Kauffman, W.K., and Paules, R.S. (1996).Faseb J. 10:238–247.
Joenje, H., LoTen, F., Oostra, A., Berkel, C.V., Rooimans, M., Schroeder, S., Kurth, T., Wegner, R., Gille, J., Buchwald, M., and Arwert, F. (1995).Blood 86:2156–2160.
Lydall, D., and Weinert, T. (1996).Curr. Opin. Genet. and Devel.,6:4–11.
Hartwell, L.H., and Weinert, T.A. (1989).Science 246:629–634.
Elledge, S.J. (1996).Science 274:1664–1672.
Crompton, N.E., Michel, C., and Burkart, W. (1991). InNew Developments in Fundamental and Applied Radiobilogy (C.B. Seymour et al., Eds.), pp. 138–143. Taylor and Francis, London.
Zhou, Z., and Elledge, S.J. (1993).Cell 75:1119–1127.
Navas, T.A., Zhou, A., and Elledge, S.J. (1995).Cell 80:29–39.
Navas, T.A., Sanchez, Y., and Elledge, S.J. (1996).Genes and Devel. 10:2632–2643.
Jakobs, P.M., Sahaayaruban, P., Saito, H., Reifsteck, C., Olson, S.B., Joenje, H., Moses, R.E., and Grompe, M. (1997).Somatic Cell Molec. Genet.,22:151–157.
Gerlier, D., and Thomasset, N. (1986)J. Immunol. Methods 94:57–63.
Moses, R.E., Merkens, L.S., and Piper, M.T. (1995).Am. J. Human Genet.,57:1969.
Auerbach, A.D. (1993).Exp. Hematol.,21:731–733.
Alter, B.P. (1993).Br. J. Haematol. 85:627–630.
Losiewicz, M.D., Carlson, B.A., Kaur, G., Sausville, E.A., and Worland, P.J. (1994).Biochem. Biophysical Res. Comm.,201:589–595.
Yano, H., Nakanishi, S., Kimura, K., Hanai, N., Saitoh, Y., Fukui, Y., Nonomura, Y., and Matsuda, Y. (1993).J. Biol. Chem. 268:25846–25856.
Sun, Y., and Moses, R.E. (1991).Somat. Cell Mol. Genet. 17:229–238.
Kupfer, G.M., Yamashita, T., Naf, D., Suliman, A., Asano, S., and D'Andrea, A. (1997).Blood 90:1047–1054.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Johnstone, P., Reifsteck, C., Kohler, S. et al. Fanconi anemia group A and D cell lines respond normally to inhibitors of cell cycle regulation. Somat Cell Mol Genet 23, 371–377 (1997). https://doi.org/10.1007/BF02673747
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02673747